000 02372 a2200661 4500
005 20250517020631.0
264 0 _c20151204
008 201512s 0 0 eng d
022 _a1573-7217
024 7 _a10.1007/s10549-015-3310-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aErber, Ramona
245 0 0 _aPredictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cApr 2015
300 _a279-88 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAntigens, Neoplasm
_xgenetics
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDNA Topoisomerases, Type II
_xgenetics
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aPrognosis
650 0 4 _aProportional Hazards Models
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aRisk
650 0 4 _aTaxoids
_xadministration & dosage
650 0 4 _aTissue Inhibitor of Metalloproteinase-1
_xmetabolism
650 0 4 _aTreatment Outcome
700 1 _aGluz, Oleg
700 1 _aBrünner, Nils
700 1 _aKreipe, Hans Heinrich
700 1 _aPelz, Enrico
700 1 _aKates, Ronald
700 1 _aBartels, Annette
700 1 _aHuober, Jens
700 1 _aMohrmann, Svjetlana
700 1 _aMoustafa, Zehra
700 1 _aLiedtke, Cornelia
700 1 _aMöbus, Volker
700 1 _aAugustin, Doris
700 1 _aThomssen, Christoph
700 1 _aJänicke, Fritz
700 1 _aKiechle, Marion
700 1 _aKuhn, Walther
700 1 _aNitz, Ulrike
700 1 _aHarbeck, Nadia
700 1 _aHartmann, Arndt
773 0 _tBreast cancer research and treatment
_gvol. 150
_gno. 2
_gp. 279-88
856 4 0 _uhttps://doi.org/10.1007/s10549-015-3310-x
_zAvailable from publisher's website
999 _c24660009
_d24660009